In mouse models with a deadly form of pediatric brain cancer, an immune stimulatory gene therapy increased median survival.

When researchers study rare diseases, breakthroughs can be made that help patients. Revisit studies that are putting genetic puzzle pieces together to tackle these conditions.

Brain cancer researchers discover an intracellular signaling pathway active in glioma cells that regulates the tumor microenvironment.

Michigan Medicine joins exclusive, global network that helps press gas on linking children with incurable brain cancer to promising clinical trials.

In the lab, Michigan Medicine researchers are developing new approaches to tackling this deadly type of brain cancer.

New basic science and clinical research identifies TAU, the same protein studied in the development of Alzheimer’s, as a biomarker for glioma development.